BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34845306)

  • 21. The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease.
    Porten SP; Cooperberg MR; Carroll PR
    BJU Int; 2010 Feb; 105(4):472-5. PubMed ID: 19681901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical margin length and location affect recurrence rates after robotic prostatectomy.
    Dev HS; Wiklund P; Patel V; Parashar D; Palmer K; Nyberg T; Skarecky D; Neal DE; Ahlering T; Sooriakumaran P
    Urol Oncol; 2015 Mar; 33(3):109.e7-13. PubMed ID: 25512161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI-derived tumor volume as a predictor of biochemical recurrence and adverse pathology in patients after radical prostatectomy: a propensity score matching study.
    Zhu X; Liu Z; He J; Li Z; He W; Lu J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8853-8861. PubMed ID: 37148292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
    De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
    Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.
    Ha YS; Kang DI; Kim JH; Joung JY; Yu J; Parihar JS; Salmasi AH; Horie S; Kim WJ; Yi Kim I
    Can J Urol; 2014 Jun; 21(3):7290-7. PubMed ID: 24978359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimising preoperative risk stratification tools for prostate cancer using mpMRI.
    Reisæter LAR; Fütterer JJ; Losnegård A; Nygård Y; Monssen J; Gravdal K; Halvorsen OJ; Akslen LA; Biermann M; Haukaas S; Rørvik J; Beisland C
    Eur Radiol; 2018 Mar; 28(3):1016-1026. PubMed ID: 28986636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
    Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
    Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.
    Takeshima Y; Yamada Y; Teshima T; Fujimura T; Kakutani S; Hakozaki Y; Kimura N; Akiyama Y; Sato Y; Kawai T; Yamada D; Kume H
    BMC Cancer; 2021 May; 21(1):501. PubMed ID: 33947348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Low-risk Prostate Cancer Really Low-risk? Consider Factors Affecting Biochemical Recurrence and Tumour Upgrade.
    Sogutdelen E; Citamak B
    J Coll Physicians Surg Pak; 2023 Feb; 33(2):193-198. PubMed ID: 36797630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer.
    Merrill MM; Lane BR; Reuther AM; Zhou M; Magi-Galluzzi C; Klein EA
    Urology; 2007 Aug; 70(2):294-8. PubMed ID: 17826492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy.
    Takeuchi N; Sakamoto S; Nishiyama A; Horikoshi T; Yamada Y; Iizuka J; Maimaiti M; Imamura Y; Kawamura K; Imamoto T; Komiya A; Ikehara Y; Akakura K; Ichikawa T
    Clin Genitourin Cancer; 2018 Aug; 16(4):e817-e829. PubMed ID: 29576444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Learning curve of minimally invasive radical prostatectomy: Comprehensive evaluation and cumulative summation analysis of oncological outcomes.
    Sivaraman A; Sanchez-Salas R; Prapotnich D; Yu K; Olivier F; Secin FP; Barret E; Galiano M; Rozet F; Cathelineau X
    Urol Oncol; 2017 Apr; 35(4):149.e1-149.e6. PubMed ID: 28117215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons.
    Silberstein JL; Su D; Glickman L; Kent M; Keren-Paz G; Vickers AJ; Coleman JA; Eastham JA; Scardino PT; Laudone VP
    BJU Int; 2013 Feb; 111(2):206-12. PubMed ID: 23356747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.
    Chung DY; Koh DH; Goh HJ; Kim MS; Lee JS; Jang WS; Choi YD
    BMC Cancer; 2018 Nov; 18(1):1057. PubMed ID: 30382916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.
    Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD
    BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.